Kumar Prabhash

Researcher Next ID · RN-037263

Researcher · Biochemistry, Genetics and Molecular Biology

Mumbai, India

Accepting doctoral researchersFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Lung Cancer Treatments and Mutations

Head and Neck Cancer Studies

Lung Cancer Research Studies

Lung Cancer Diagnosis and Treatment

Cancer Genomics and Diagnostics

First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study
The Lancet · 2023 · https://doi.org/10.1016/s0140-6736(23)00774-2
Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data
The Oncologist · 2017 · https://doi.org/10.1634/theoncologist.2017-0015
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(14)60845-x
Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study
Journal of Thoracic Oncology · 2012 · https://doi.org/10.1097/jto.0b013e31826aec2b

No projects listed.